Study guide

14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis

NPLEX Part I — Biomedical Sciences Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Pacing, and GEA Strategy

1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards

2 Chapter 2: Gross Anatomy & Musculoskeletal System

2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures

3 Chapter 3: Histology & Microscopic Anatomy

3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium

4 Chapter 4: Neuroanatomy & Special Senses

4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation

5 Chapter 5: Embryology & Developmental Anatomy

5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology

6 Chapter 6: Cellular & General Physiology

6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle

7 Chapter 7: Cardiovascular & Respiratory Physiology

7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing

8 Chapter 8: Renal, Fluid, & Acid-Base Physiology

8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology

9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation

10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism

10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport

11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics

11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics

12 Chapter 12: Immunology & Immunopathology

12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types

13 Chapter 13: Medical Microbiology

13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens

14 Chapter 14: General Pathology & Neoplasia

14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors

15 Chapter 15: Systems Pathology & Disease Mechanisms

15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract

14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis

Key Takeaways Explain This Topic AI

Cellular adaptations include hypertrophy (cell size), hyperplasia (cell number), atrophy, metaplasia (stem cell reprogramming), and dysplasia (disordered growth).

Reversible injury features decreased ATP, Na+/K+ pump failure, hydropic swelling, ribosomal detachment, blebbing, and chromatin clumping.

Irreversible injury is defined by plasma membrane rupture, massive Ca2+ influx activating intracellular enzymes, and nuclear pyknosis, karyorrhexis, or karyolysis.

Distinct patterns of necrosis include coagulative (ischemia in solid organs except brain), liquefactive (brain infarcts, abscesses), caseous (tuberculosis), fat (pancreatitis), and fibrinoid (vasculitis).

Apoptosis occurs via intrinsic (p53, Bax/Bak, cytochrome c, Caspase 9) or extrinsic (FasL/CD95, FADD, Caspase 8) pathways converging on executioner Caspases 3 and 6.

Last updated: July 2026

14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis

Cellular pathology forms the fundamental foundation of biomedical sciences for the NPLEX Part I. Tissues continually adapt to environmental stresses, metabolic demands, and injurious stimuli. When stress exceeds adaptive capability, cellular injury occurs. Understanding the physiological spectrum from reversible cellular adaptation to cell death—via necrosis or apoptosis—is essential for diagnosing and managing systemic disease processes.

Cellular Adaptations to Environmental Stress

Cellular adaptation represents a reversible structural or functional response to physiological or pathological stimuli. When cells encounter altered demands, they adapt through five classic mechanisms:

Adaptation Type Cellular Mechanism Classic Examples Key Clinical Implications

Hypertrophy Increase in cell size via gene activation, increased protein synthesis, and organelle assembly. Left ventricular hypertrophy (LVH) in hypertension; skeletal muscle hypertrophy in weightlifting. No new cells are formed; driven by mechanical stretch and trophic signals (e.g., endothelin-1, IGF-1).

Hyperplasia Increase in cell number via stem cell proliferation and growth factor signaling. Benign prostatic hyperplasia (BPH); endometrial hyperplasia from unopposed estrogen. Occurs only in tissues capable of division; pathologic hyperplasia increases risk for dysplasia/carcinoma.

Atrophy Decrease in cell size and number via ubiquitin-proteasome degradation and autophagic vacuoles. Denervation atrophy of muscle; senile brain atrophy; adrenal atrophy following exogenous steroids. Ubiquitin ligases tag intermediate filaments for proteasome destruction; autophagy clears organelles.

Metaplasia Reprogramming of tissue stem cells resulting in replacement of one mature cell type by another. Barrett esophagus (squamous to non-ciliated columnar with goblet cells); respiratory tract in smokers. Fully reversible if noxious stimulus is removed; persistent stimulus predisposes to malignant transformation.

Dysplasia Disordered cellular growth and maturation with loss of architectural orientation. Cervical intraepithelial neoplasia (CIN); actinic keratosis of the skin. Pre-neoplastic change; features pleomorphism, nuclear hyperchromasia, and increased mitotic figures.

Reversible Cell Injury

When an injurious stimulus (such as hypoxia, ischemia, toxic exposure, or nutritional deficiency) impairs cellular function without breaching critical survival thresholds, reversible injury occurs. The central biochemical trigger is decreased oxidative phosphorylation and reduced ATP synthesis.

Pathophysiology of Reversible Damage

Failure of the Na+/K+-ATPase Pump: Depletion of ATP halts active ion transport, causing intracellular accumulation of sodium and water. This results in cellular swelling (hydropic change) and swelling of the endoplasmic reticulum.

Switch to Anaerobic Glycolysis: Decreased oxygen forces reliance on anaerobic glycolysis, leading to glycogen depletion and intracellular accumulation of lactic acid. The resulting intracellular acidosis causes chromatin clumping.

Ribosomal Detachment: Swelling of the rough endoplasmic reticulum causes ribosomes to detach, markedly impairing protein synthesis.

Morphological Hallmarks: Reversible injury is characterized microscopically by microvascular blebbing, loss of microvilli, mitochondrial swelling, and fatty change (steatosis) in lipid-metabolizing organs like the liver.

Irreversible Cell Injury and Cell Death

The transition from reversible to irreversible cell injury is marked by a point of no return. Two principal biochemical events define irreversible cell death: severe plasma membrane damage and mitochondrial permeability transition (MPT) pore opening .

Key Mechanisms of Irreversibility

Calcium Influx: Severe membrane breakdown allows a massive influx of extracellular calcium into the cytosol. Elevated intracellular Ca2+ aberrantly activates destructive enzymes:

Phospholipases: Degrade plasma and organellar membrane phospholipids.

Proteases: Cleave cytoskeletal proteins, disrupting structural integrity.

Endonucleases: Break down genomic DNA into fragments.

ATPases: Accelerate total ATP depletion.

Mitochondrial Permeability Transition: Irreversible pore opening in the inner mitochondrial membrane dissipates the proton gradient, ending ATP production and triggering the release of pro-apoptotic proteins like cytochrome c .

Morphological Nuclear Alterations

As nuclear degradation proceeds, three distinct nuclear phases are visualized sequentially:

Pyknosis: Nuclear condensation characterized by a small, dense, hyperchromatic mass.

Karyorrhexis: Fragmentation of the pyknotic nucleus into nuclear dust.

Karyolysis: Complete enzymatic dissolution of the nucleus via deoxyribonuclease (DNase) activity.

Patterns of Tissue Necrosis

Necrosis is uncontrolled cell death resulting from severe exogenous injury. It is always pathological, involves large groups of cells, and provokes an acute inflammatory response. Injury / Ischemia / Infection / Toxicity

  • \u2502
  • \u25bc
  • Cellular & Organelle Swelling
  • \u2502
  • \u25bc
  • Severe Plasma Membrane Damage
  • \u2502
  • \u25bc
  • Enzymatic Digestion & Leakage
  • \u2502
  • \u25bc
  • Acute Inflammatory Response
  • The Six Classic Morphological Types of Necrosis

Coagulative Necrosis:

Mechanism: Denaturation of cellular structural proteins outweighs enzymatic digestion. Tissue architecture is preserved for days as pale, firm, wedge-shaped infarcts.

Etiology: Ischemic infarction in all solid organs (heart, kidney, spleen) EXCEPT the brain .

Liquefactive Necrosis:

Mechanism: Enzymatic lysis by lysosomal enzymes degrades tissue into a liquid viscous mass.

Etiology: Hypoxic/ischemic infarction of the central nervous system (brain) due to abundant microglial enzymes and lipid content; bacterial abscesses due to neutrophil proteolytic enzymes.

Caseous Necrosis:

Mechanism: Combined coagulative and liquefactive features. Grossly appears cheesy, friable, and white. Histologically shows acellular granular debris surrounded by a granulomatous rim.

Etiology: Classic for Tuberculosis (Mycobacterium tuberculosis) and systemic fungal infections ( Histoplasma , Coccidioides ).

Fat Necrosis:

Mechanism: Release of pancreatic lipases or direct trauma frees fatty acids, which combine with extracellular calcium to form chalky white soap deposits ( saponification ).

Etiology: Acute pancreatitis (peripancreatic fat) and blunt breast trauma.

Fibrinoid Necrosis:

Mechanism: Antigen-antibody immune complexes deposit in arterial walls alongside leaking fibrin, creating a bright pink, amorphous vessel wall appearance on H&E stain.

Etiology: Malignant hypertension, vasculitides (e.g., polyarteritis nodosa), and hyperacute transplant rejection.

Gangrenous Necrosis:

Dry Gangrene: Coagulative necrosis involving a distal limb due to severe arterial occlusion (ischemic necrosis without infection).

Wet Gangrene: Superadded bacterial infection causing liquefactive necrosis superimposed on coagulative necrosis.

Apoptosis: Programmed Cell Death

Unlike necrosis, apoptosis is an energy-dependent, strictly regulated form of programmed cell death. It affects single cells or small cell clusters, does not cause membrane rupture, and does NOT elicit an inflammatory response . Apoptotic bodies are rapidly phagocytosed by macrophages. INTRINSIC PATHWAY EXTRINSIC PATHWAY

  • (DNA Damage / p53 Activation) (FasL / TNF-alpha Binding)
  • \u2502 \u2502
  • \u25bc \u25bc
  • Bax/Bak Insertion into Mitochondria FADD Recruitment
  • \u2502 \u2502
  • \u25bc \u25bc
  • Cytochrome c Release Caspase 8 Activation
  • \u2502 \u2502
  • \u25bc \u2502
  • Caspase 9 Activation \u2502
  • \u2502 \u2502

\u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u252c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518

  • \u2502
  • \u25bc
  • Executioner Caspases (3 & 6)
  • \u2502
  • \u25bc
  • Endonuclease & Protease Lysis
  • \u2502
  • \u25bc
  • Apoptotic Bodies
  • Pathways of Apoptotic Induction

Intrinsic (Mitochondrial) Pathway:

Trigger: Cell stress, DNA damage, radiation, or growth factor deprivation.

Mechanism: Sensor proteins activate p53, which upregulates pro-apoptotic proteins Bax and Bak . Bax/Bak form oligomers in the outer mitochondrial membrane, inhibiting anti-apoptotic Bcl-2 and Bcl-xL .

Cascade: Cytochrome c leaks into the cytosol, binds APAF-1 to form the apoptosome, and activates Caspase 9 .

Extrinsic (Death Receptor) Pathway:

Trigger: Ligand binding to cell surface death receptors (TNF receptor family).

Mechanism: FasL binding to Fas (CD95) or TNF-alpha binding to TNFR recruits the FADD (Fas-associated death domain) adapter protein.

Cascade: FADD directly activates Caspase 8 .

Perforin/Granzyme B Pathway:

Trigger: Cytotoxic CD8+ T cells and Natural Killer (NK) cells recognize viral or tumor antigens.

Mechanism: CD8+ T cells secrete perforin (creates transmembrane pores) and granzyme B (cleaves and directly activates executioner caspases).

Execution Phase of Apoptosis

Both the intrinsic and extrinsic pathways converge on the activation of executioner caspases (Caspase 3 and Caspase 6) . Executioner caspases activate endonucleases (cleaving DNA into 180-base-pair ladder fragments) and degrade cytoskeletal proteins, leading to cell shrinkage, nuclear pyknosis, and formation of membrane-bound apoptotic bodies.